Implementing Quality and Value in HCT

Minneapolis, MN US
October 19, 2016 to October 20, 2016

The predicted growth in healthcare spending augments pressure by those within the healthcare system to contain costs and focus on quality and value of healthcare. Hematopoietic cell transplantation (HCT) represents only a fraction of the total dollars spent on healthcare but it is an expensive therapy and increases in transplant related expenditures are rising faster than other areas of healthcare.

This forum is the fourth installment in a series of meetings designed to understand, plan and implement quality and value initiatives in the HCT community. The initiatives will address patient-centered care coordination, quality of life, facilitating centers’ quality improvement efforts, emerging reimbursement models and early referral to transplant.


ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and National Marrow Donor Program. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 11 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 11 hours of participation for continuing education for allied health professionals.  

Target Audience

HCT Program Administrators

Learning Objectives

At the conclusion of this activity, learners will be able to:

  1. Describe the need for quality and value initiatives within the HCT community to drive patient centered high-value healthcare
  2. Identify a consensus of quality and value initiatives in HCT, particularly, patient-centered care coordination, early referral to transplant and emerging reimbursement models.
  3. Develop actionable next steps to implement the selected quality and value initiatives. 
Additional information


Nicole Heino
Phone Number: 
+1 (763) 406-4811
Course summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 11.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
10/19/2016 - 8:00am CDT
Event ends: 
10/20/2016 - 8:00am CDT
National Marrow Donor Program
500N 5th Street
Minneapolis, MN 55401
United States
Planning Committee:
J. Douglas Rizzo, MD, MS
Krishna Komanduri, MD
Elizabeth Murphy, EdD, RN
Stephanie Farnia, MPH
Alicia Silver, MPP
Kristen Edsall, RN BSN MSN
Ruth Brentari, MHA
Nicole Heino
Lauren Marks
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  
Krishna Komanduri, MDNovartisCommittee member
Richard Maziarz, MDAthersys, Inc. Novartis, IncyteConsultant, Advisory Board
Daniel Weisdorf, MDKadmon, EnivexConsultant
Nandita KheraNovartisConsultant
Brennan McNallyUnited Health GroupEmployee
Anthony BonaguraOptum, Inc.Employee
Navneet MajhalAnthem, Inc.Committee Member


In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

Available Credit

  • 11.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 11.00 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.